Adheris Study Finds Antidepressant Discontinuation Most Likely At The Start Of Therapy Among Newly Treated And Previously Lapsed Patients

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to [...]

Harley Medical Group Reveal Patients Working Overtime To Fund Surgery

Harley Medical Group, the UK’s largest cosmetic surgery provider, has found that a growing number of patients are funding their cosmetic surgery procedures by working a second job or putting in extra hours due to the current poor economic climate.

Tags: 12 months, amp, br, bri, cardiff, ced, choices, Commission, cte, ec, [...]

Toddlers’ Focus On Mouths Rather Than On Eyes Is A Predictor Of Autism Severity

Scientists at Yale School of Medicine have found that two-year-olds with autism looked significantly more at the mouths of others, and less at their eyes, than typically developing toddlers. This abnormality predicts the level of disability, according to study results published in the Archives of General Psychiatry.

Tags: aim, amount of time, [...]

New Bio-Imaging Mass Spectrometry Center At Georgia Tech Aims To Unravel The Molecular Complexities Of Biological Systems

Understanding biology at the systems level is difficult, especially when studying complex specimens like tissue slices or communities of organisms in a biofilm. Scientists must be able to identify, quantify and locate the molecules present in the samples.

Tags: aim, ala, amino acids, amp, Analysis, analytical chemistry, assistant, assistant professor, biofilm, biological [...]

Analysis Of Earlier European Stroke Trial Supports Treatment Regimen For Viprinex(TM) In Current International Phase 3 Clinical Trials

Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII) announced that previously found excess symptomatic intracranial hemorrhage in an earlier European trial of ancrod (now Viprinex(TM)) for the treatment of acute ischemic stroke may be minimized with avoidance of prolonged low levels of fibrinogen and use of common blood pressure entry criteria.

[...]